Publications
-
Utility of atypical antipsychotics in the treatment of resistant unipolar depression.
DeBattista C,
Hawkins J.
CNS Drugs.
2009;
23
(5):
369-77
-
Effects of major depression diagnosis and cortisol levels on indices of neurocognitive function.
Gomez RG,
Posener JA, Keller J, DeBattista C, Solvason B, Schatzberg AF.
Psychoneuroendocrinology.
2009;
34
(7):
1012-8
-
A multisite trial of mifepristone for the treatment of psychotic depression: a site-by-treatment interaction.
Blasey CM,
Debattista C, Roe R, Block T, Belanoff JK.
Contemp Clin Trials.
2009;
30
(4):
284-8
-
Sildenafil treatment of women with antidepressant-associated sexual dysfunction: a randomized controlled trial.
Nurnberg HG,
Hensley PL, Heiman JR, Croft HA, Debattista C, Paine S.
JAMA.
2008;
300
(4):
395-404
-
Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness.
Fava M,
Thase ME, DeBattista C, Doghramji K, Arora S, Hughes RJ.
Ann Clin Psychiatry.
2007 Jul-Sep;
19
(3):
153-9
-
The neuropsychological profile of psychotic major depression and its relation to cortisol.
Gomez RG,
Fleming SH, Keller J, Flores B, Kenna H, DeBattista C, Solvason B, Schatzberg AF.
Biol Psychiatry.
2006;
60
(5):
472-8
-
Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression.
DeBattista C,
Belanoff J, Glass S, Khan A, Horne RL, Blasey C, Carpenter LL, Alva G.
Biol Psychiatry.
2006;
60
(12):
1343-9
-
The use of mifepristone in the treatment of neuropsychiatric disorders.
DeBattista C,
Belanoff J.
Trends Endocrinol Metab.
2006;
17
(3):
117-21
-
Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12-week, open-label, extension study.
Thase ME,
Fava M, DeBattista C, Arora S, Hughes RJ.
CNS Spectr.
2006;
11
(2):
93-102
-
The efficacy of mifepristone in the reduction and prevention of olanzapine-induced weight gain in rats.
Beebe KL,
Block T, Debattista C, Blasey C, Belanoff JK.
Behav Brain Res.
2006;
171
(2):
225-9
-
Augmentation and combination strategies for depression.
DeBattista C,
J Psychopharmacol.
2006;
20
(3 Suppl):
11-8
-
Detecting psychotic major depression using psychiatric rating scales.
Keller J,
Gomez RG, Kenna HA, Poesner J, DeBattista C, Flores B, Schatzberg AF.
J Psychiatr Res.
2006;
40
(1):
22-9
-
Update on augmentation of antidepressant response in resistant depression.
DeBattista C,
Lembke A.
Curr Psychiatry Rep.
2005;
7
(6):
435-40
-
The efficacy of divalproex sodium in the treatment of agitation associated with major depression.
Debattista C,
Solomon A, Arnow B, Kendrick E, Tilston J, Schatzberg AF.
J Clin Psychopharmacol.
2005;
25
(5):
476-9
-
Executive dysfunction in major depressive disorder.
DeBattista C,
Expert Rev Neurother.
2005;
5
(1):
79-83
-
A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction.
DeBattista C,
Solvason B, Poirier J, Kendrick E, Loraas E.
J Clin Psychiatry.
2005;
66
(7):
844-8
-
C-1073 (mifepristone) in the adjunctive treatment of Alzheimer's disease.
DeBattista C,
Belanoff J.
Curr Alzheimer Res.
2005;
2
(2):
125-9
-
A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness.
Fava M,
Thase ME, DeBattista C.
J Clin Psychiatry.
2005;
66
(1):
85-93
-
HPA axis activation in major depression and response to fluoxetine: a pilot study.
Young EA,
Altemus M, Lopez JF, Kocsis JH, Schatzberg AF, DeBattista C, Zubieta JK.
Psychoneuroendocrinology.
2004;
29
(9):
1198-204
-
A prospective trial of modafinil as an adjunctive treatment of major depression.
DeBattista C,
Lembke A, Solvason HB, Ghebremichael R, Poirier J.
J Clin Psychopharmacol.
2004;
24
(1):
87-90
-
Fetal heart rate decelerations during ECT-induced seizures: is it important?
DeBattista C,
Cochran M, Barry JJ, Brock-Utne JG.
Acta Anaesthesiol Scand.
2003;
47
(1):
101-3
-
A prospective trial of bupropion SR augmentation of partial and non-responders to serotonergic antidepressants.
DeBattista C,
Solvason HB, Poirier J, Kendrick E, Schatzberg AF.
J Clin Psychopharmacol.
2003;
23
(1):
27-30
-
The timing of electroconvulsive therapy and bispectral index after anesthesia induction using different drugs does not affect seizure duration.
Lemmens HJ,
Levi DC, Debattista C, Brock-Utne JG.
J Clin Anesth.
2003;
15
(1):
29-32
-
Safety of antidepressants in the elderly.
Sommer BR,
Fenn H, Pompei P, DeBattista C, Lembke A, Wang P, Flores B.
Expert Opin Drug Saf.
2003;
2
(4):
367-83
-
Seizure duration with remifentanil/methohexital vs. methohexital alone in middle-aged patients undergoing electroconvulsive therapy.
Smith DL,
Angst MS, Brock-Utne JG, DeBattista C.
Acta Anaesthesiol Scand.
2003;
47
(9):
1064-6
-
Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study.
DeBattista C,
Doghramji K, Menza MA, Rosenthal MH, Fieve RR.
J Clin Psychiatry.
2003;
64
(9):
1057-64
-
Slowing the progression of cognitive decline in Alzheimer's disease using mifepristone.
Belanoff JK,
Jurik J, Schatzberg LD, DeBattista C, Schatzberg AF.
J Mol Neurosci.
2002 Aug-Oct;
19
(1-2):
201-6
-
An open label trial of C-1073 (mifepristone) for psychotic major depression.
Belanoff JK,
Rothschild AJ, Cassidy F, DeBattista C, Baulieu EE, Schold C, Schatzberg AF.
Biol Psychiatry.
2002;
52
(5):
386-92
-
Sertraline versus imipramine to prevent relapse in chronic depression.
Koran LM,
Gelenberg AJ, Kornstein SG, Howland RH, Friedman RA, DeBattista C, Klein D, Kocsis JH, Schatzberg AF, Thase ME, Rush AJ, Hirschfeld RM, LaVange LM, Keller MB.
J Affect Disord.
2001;
65
(1):
27-36
-
Is electroconvulsive therapy effective for the depressed patient with comorbid borderline personality disorder?
DeBattista C,
Mueller K.
J ECT.
2001;
17
(2):
91-8
-
Psychopharmacologic treatment strategies for depression, bipolar disorder, and schizophrenia.
Glick ID,
Suppes T, DeBattista C, Hu RJ, Marder S.
Ann Intern Med.
2001;
134
(1):
47-60
-
Cortisol feedback during the HPA quiescent period in patients with major depression.
Posener JA,
DeBattista C, Williams GH, Schatzberg AF.
Am J Psychiatry.
2001;
158
(12):
2083-5
-
Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness.
Schatzberg AF,
Posener JA, DeBattista C, Kalehzan BM, Rothschild AJ, Shear PK.
Am J Psychiatry.
2000;
157
(7):
1095-100
-
Pramipexole augmentation of a selective serotonin reuptake inhibitor in the treatment of depression.
DeBattista C,
Solvason HB, Breen JA, Schatzberg AF.
J Clin Psychopharmacol.
2000;
20
(2):
274-5
-
Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients: a double-blind, placebo-controlled study.
DeBattista C,
Posener JA, Kalehzan BM, Schatzberg AF.
Am J Psychiatry.
2000;
157
(8):
1334-7
-
24-Hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression.
Posener JA,
DeBattista C, Williams GH, Chmura Kraemer H, Kalehzan BM, Schatzberg AF.
Arch Gen Psychiatry.
2000;
57
(8):
755-60
-
Phenomenology and treatment of agitation.
Schatzberg AF,
DeBattista C.
J Clin Psychiatry.
1999:
60 Suppl 15
17-20
-
Negative-pressure pulmonary edema: a potential hazard in patients undergoing ECT.
Cochran M,
DeBattista C, Schmiesing C, Brock-Utne JG.
J ECT.
1999;
15
(2):
168-70
-
The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder.
Crismon ML,
Trivedi M, Pigott TA, Rush AJ, Hirschfeld RM, Kahn DA, DeBattista C, Nelson JC, Nierenberg AA, Sackeim HA, Thase ME.
J Clin Psychiatry.
1999;
60
(3):
142-56
-
Developing treatment algorithms for unipolar depression in Cyberspace: International Psychopharmacology Algorithm Project (IPAP).
Trivedi MH,
DeBattista C, Fawcett J, Nelson C, Osser DN, Stein D, Jobson K.
Psychopharmacol Bull.
1998;
34
(3):
355-9
-
Serotonergic synergism: the risks and benefits of combining the selective serotonin reuptake inhibitors with other serotonergic drugs.
DeBattista C,
Sofuoglu M, Schatzberg AF.
Biol Psychiatry.
1998;
44
(5):
341-7
-
ECT in dissociative identity disorder and comorbid depression.
DeBattista C,
Solvason HB, Spiegel D.
J ECT.
1998;
14
(4):
275-9
-
Treatment of psychotic depression.
Debattista C,
Solvason HB, Belanoff J, Schatzberg AF.
Am J Psychiatry.
1997;
154
(11):
1625-6
-
Development of obsessive symptoms during nefazodone treatment.
Sofuoglu M,
Debattista C.
Am J Psychiatry.
1996;
153
(4):
577-8
-
Physical symptoms associated with paroxetine withdrawal.
Debattista C,
Schatzberg AF.
Am J Psychiatry.
1995;
152
(8):
1235-4
-
Sumatriptan prophylaxis for postelectroconvulsive therapy headaches.
DeBattista C,
Mueller K.
Headache.
1995;
35
(8):
502-3
Help